Skip to main content
NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
NO

Novocure Ltd (NVCR)

NASDAQ • Healthcare

$15.63
-$1.22 (-7.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$16.56
Previous Close$15.63
Day Range$15.6 - $16.65
Avg. Volume (3M)1.1M
Market Cap$1.8B
52 Week Range
$9.82$21.45
Next EarningsIn 49 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$183.5M100%
Gross Profitminus cost of goods$142.4M78%

In plain terms: out of every $100 in revenue, Novocure Ltd currently loses $9.

Fundamentals & Financials

Revenue (TTM)
$699.1M
Net Income (TTM)
-$148.5M
EPS (TTM)
-$1.3
ROA (TTM)
-18.68%
Current Ratio
2.89
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+46.3%Q1 2026-$0.22
-21.0%Q2 2026-$0.62
+60.8%Q3 2026-$0.13
Next

Oct 29

in 49 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Novocure Ltd

Novocure Ltd is a healthcare company listed on NASDAQ as NVCR that develops, manufactures, and commercializes tumor treating fields (TTFields) devices for solid tumor cancers. Its device portfolio includes Optune Gio, Optune Lua, and Optune Pax, and the business generated $655.4 million in FY2025 revenue.

Name
Novocure Ltd
CEO
Frank Leonard
Website
www.novocure.com
Industry
Healthcare
Year Founded
2000
Employees
1,605

Today's Snapshot

AI-generated

So far today, NVCR is trading 0.6% lower at 15.54, while its sector was flat.

Trading Volume

Below 10d avg (893.4K)

485.4K

vs S&P 500 Today

Inline with Market

-0.01%

Updated: September 10, 2026 at 16:47 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
NVCR carries a Sell bias driven by deteriorating momentum and a cluster of bearish short- and medium-term indicators. CCI is deeply negative and momentum and MACD are also weak, with price trading below its 10- to 100-period averages, while ADX around the low 20s shows only moderate trend strength. Although the shares remain above the 200-day average and Bollinger readings suggest an oversold extension, VWAP and on-balance-volume are unfavorable and intraday volatility is elevated. Technical takeaway: Sell — short-to-medium-term momentum and moving averages weigh on the setup despite the 200-day support.
All signals
  • EMA (5 indicators)$14.80 - $17.05
    Sell
  • RSI (14)38.46
    Neutral
  • Stochastic %K (14, 3, 3)11.14
    Buy
  • MACD Level (12, 26)-0.08
    Sell

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
NEOGNeogen Corporation
$11.92+0.3%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
AZTAAzenta, Inc.
$30.15-2.2%
STAASTAAR Surgical Company
$23.62-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.